glp-1 microneedle patch Counterfeit weight loss products claiming to contain GLP-1 Patches: What are They,

Sustainable Tourism in Peru, Eco-friendly destinations, responsible accommodations and tips to minimize your impact on local communities.

Ensuring equitable access and strengthening health systems will be essential to prevent widening health disparities.AgendaCo-chairsDr Luz de Regil Director, Department of Nutrition and Food Safety, WHO and Dr Kirsten Bibbins Domingo Editor-in-Chief, JAMAModeratorDr Gaya Manori Gamhewage, Director, Department of Communication, WHOWelcomingDr Luz De Regil Director NFS, WHO and Dr Kirsten Bibbins-Domingo, Editor-in-Chief, JAMAPresentation:WHO guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adultsDr Francesca Celletti, Senior Advisor Obesity, Department of Nutrition and Food Safety, WHO and Dr

New research presented at the Endocrine Society's ENDO 2026 meeting is generating interest among clinicians who manage obesity, testosterone deficiency, and male reproductive health

Novo Nordisk's Wegovy pill expands obesity drug market Novo Nordisk's oral GLP-1 treatment, the Wegovy pill, has seen high demand since its January launch, attracting patients who previously avoided injections due to needle fear or high costs

Safe, medical weight loss support with proven results